M. Barry

发表

The cost-effectiveness of cotrimoxazole prophylaxis in HIV-infected children in Zambia

M. Sculpher, A. Walker, S. Griffin, 2008, AIDS.

Effects ofdideoxyinosine anddideoxycytidine on the intracellular phosphorylation ofzidovudine inhuman mononuclear cells

D. Back, M. Barry, G. Veal, 1994 .

Effects of dideoxyinosine and dideoxycytidine on the intracellular phosphorylation of zidovudine in human mononuclear cells.

D. Back, M. Barry, G. Veal, 1994, British journal of clinical pharmacology.

Zidovudine therapy in HIV infection: which patients should be treated and when.

A. Breckenridge, D. Back, M. Barry, 1995, British journal of clinical pharmacology.

The effects of indomethacin and naproxen on zidovudine pharmacokinetics.

N. Beeching, A. Breckenridge, D. Back, 1993, British journal of clinical pharmacology.

The pharmacokinetics of methadone in HIV-positive patients receiving the non-nucleoside reverse transcriptase inhibitor efavirenz.

D. Back, M. Barry, H. Reynolds, 2001, British journal of clinical pharmacology.

Enzyme induction and inhibition.

M. Barry, J. Feely, 1990, Pharmacology & therapeutics.

St Johns wort increases expression of P-glycoprotein: implications for drug interactions.

D. Back, M. Barry, J. Feely, 2002, British journal of clinical pharmacology.

Zidovudine pharmacokinetics in zidovudine-induced bone marrow toxicity.

N. Beeching, A. Breckenridge, D. Back, 1994, British journal of clinical pharmacology.

Pharmacokinetics of zidovudine and dideoxyinosine alone and in combination in patients with the acquired immunodeficiency syndrome.

N. Beeching, A. Breckenridge, D. Back, 1994, British journal of clinical pharmacology.

Severity of cirrhosis and the relationship of α1‐acid glycoprotein concentration to plasma protein binding of lidocaine

M. Barry, D. Weir, J. Feely, 1990 .

Effects of drugs on 2',3'-dideoxy-2',3'-didehydrothymidine phosphorylation in vitro

S. Khoo, D. Back, M. Barry, 1997, Antimicrobial agents and chemotherapy.

The effect of zidovudine dose on the formation of intracellular phosphorylated metabolites

A. Breckenridge, S. Khoo, D. Back, 1996, AIDS.

Increase in renal cytochrome P-450 and NADPH cytochrome c reductase activity following drug inhibition of hepatic monooxygenase activity.

M. Barry, J. Feely, A. Dueñas‐Laita, 1987, Biochemical pharmacology.

Effects of chronic treatment with amiodarone on hepatic demethylation and cytochrome P450

M. Barry, J. Feely, A. Dueñas‐Laita, 1987, The Journal of pharmacy and pharmacology.

Lipoprotein(a) in cirrhosis.

M. Barry, D. Weir, J. Feely, 1992, BMJ.

Reply to Calcagno et al.

C. Walsh, M. Barry, S. Schmitz, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Pharmacogenetics and drug metabolism: An Irish prspective

M. Barry, J. Feely, P. Holland, 1991, Irish journal of medical science.

In vitro screening of nucleoside analog combinations for potential use in anti-HIV therapy.

S. Khoo, D. Back, M. Barry, 1997, AIDS research and human retroviruses.

Pharmacokinetics of zidovudine and dideoxyinosine alone and in combination in children with HIV infection.

D. Back, M. Barry, D. Gibb, 1995, British journal of clinical pharmacology.

Pharmacokinetics of Zidovudine in Children with Symptomatic HIV Infection

D. Back, M. Barry, D. Gibb, 1994 .

BRODIE ENZYME INDUCTION AND INHIBITION

M. Barry, J. Feely, J. M., 2002 .

The pharmacokinetic interaction between ivacaftor and ritonavir in healthy volunteers

M. Barry, S. Schmitz, D. D'Arcy, 2017, British journal of clinical pharmacology.

Pharmacokinetic interactions of nevirapine and methadone and guidelines for use of nevirapine to treat injection drug users.

D. Back, M. Barry, H. Reynolds, 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Drug interactions with zidovudine phosphorylation in vitro

D. Back, M. Barry, G. Veal, 1995, Antimicrobial agents and chemotherapy.

Drug interactions with zidovudine phosphorylation in vitro.

D. Back, M. Barry, G. Veal, 1994, Antimicrobial agents and chemotherapy.

Zalcitabine (ddC) Phosphorylation and Drug Interactions

D. Back, M. Barry, G. Veal, 1995 .

Effect of protease inhibitors on nucleoside analogue phosphorylation in vitro.

D. Back, M. Barry, P. Hoggard, 1998, British journal of clinical pharmacology.

Differential inhibition of cytochrome P450 isoforms by the protease inhibitors, ritonavir, saquinavir and indinavir.

D. Back, M. Barry, V. Eagling, 2003, British journal of clinical pharmacology.

Interaction of sildenafil and indinavir when co-administered to HIV-positive patients.

D. Back, M. Ryan, C. Merry, 1999, AIDS.

The pharmacokinetics of lamivudine phosphorylation in peripheral blood mononuclear cells from patients infected with HIV-1.

D. Back, M. Barry, G. E. Pakes, 1999, AIDS.

Lamivudine (3TC) phosphorylation and drug interactions in vitro.

D. Back, M. Barry, G. Veal, 1997, Biochemical pharmacology.

Intracellular activation of 2',3'-dideoxyinosine and drug interactions in vitro.

D. Back, M. Barry, G. Veal, 1999, AIDS research and human retroviruses.

Variability in trough plasma saquinavir concentrations in HIV patients--a case for therapeutic drug monitoring.

D. Back, C. Merry, M. Barry, 1998, British journal of clinical pharmacology.

Zidovudine phosphorylation in HIV‐infected patients and seronegative volunteers

N. Beeching, A. Breckenridge, D. Back, 1994, AIDS.

Zidovudine Phosphorylation Determined Sequentially over 12 Months in Human Immunodeficiency Virus-Infected Patients with or without Previous Exposure to Antiretroviral Agents

C. Loveday, D. Back, M. Barry, 2001, Antimicrobial Agents and Chemotherapy.

The pharmacokinetics of combination therapy with nelfinavir plus nevirapine

A. Breckenridge, D. Back, M. Ryan, 1998, AIDS.

Interaction between lamivudine (3TC) and other nucleoside analogues for intracellular phosphorylation.

S. Khoo, D. Back, M. Barry, 1996, AIDS.

Saquinavir pharmacokinetics alone and in combination with nelfinavir in HIV‐infected patients

D. Back, C. Merry, M. Barry, 1997, AIDS.

Saquinavir pharmacokinetics alone and in combination with ritonavir in HIV‐infected patients

A. Breckenridge, D. Back, M. Ryan, 1997, AIDS.

Intracellular Accumulation of Nelfinavir and Its Relationship to P-Glycoprotein Expression and Function in HIV-Infected Patients

D. Back, M. Barry, F. Mulcahy, 2004, Antiviral therapy.

Intracellular Indinavir Pharmacokinetics in HIV-Infected Patients: Comparison with Plasma Pharmacokinetics

S. Khoo, D. Back, M. Barry, 2002, Antiviral therapy.

Therapeutic drug monitoring of antiretrovirals in human immunodeficiency virus infection.

S. Khoo, D. Back, C. Merry, 2000, Therapeutic drug monitoring.

Antiretroviral therapy for patients with HIV disease.

D. Back, M. Barry, F. Mulcahy, 1998, British journal of clinical pharmacology.

Plasma Protein Binding of Lidocaine and Warfarin in Insulin-Dependent and Non-Insulin-Dependent Diabetes Mellitus

M. Barry, M. Cullen, J. Feely, 1993, Clinical Pharmacokinetics.

Effect of zinc supplementation on oxidative drug metabolism in patients with hepatic cirrhosis.

P. Macmathuna, M. Barry, J. Feely, 1991, British journal of clinical pharmacology.

National scientific medical meeting 1997 abstracts

G. S. Nesbitt, R. Segurado, D. Sibley, 1998, Irish journal of medical science.

Toxic shock syndrome in a penicillin sensitive patient

M. Barry, J. Feely, P. M. Mathuna, 1987, Irish journal of medical science.

Intracellular glutathione in the peripheral blood cells of HIV-infected patients: failure to show a deficiency

Dominic P. Williams, M. Pirmohamed, A. Breckenridge, 1996, AIDS.

Tissue zinc status and drug elimination in patients with chronic liver disease.

M. Barry, J. Feely, P. Keeling, 1990, Clinical science.

Improved tolerability of ritonavir derived from pharmacokinetic principles.

D. Back, C. Merry, M. Barry, 1996, British Journal of Clinical Pharmacology.

Royal academy of medicine in ireland section of biological sciences: Proceedings of meeting held on 3rd January, 1986.

H. Redmond, W. Kernohan, K. Stafford, 1986 .

Drug interactions in HIV infection

D. Back, M. Barry, S. Gibbons, 1999 .

Metabolism of didanosine (ddI) by erythrocytes: pharmacokinetic implications.

N. Beeching, D. Back, M. Barry, 1993, British Journal of Clinical Pharmacology.

Severity of cirrhosis and the relationship of alpha 1-acid glycoprotein concentration to plasma protein binding of lidocaine.

M. Barry, D. Weir, J. Feely, 1990, Clinical pharmacology and therapeutics.